Does pharmacological conditioning with the volatile anaesthetic sevoflurane offer protection in liver surgery?

HPB

Volumn 14, Issue 12, 2012, Pages 854-862

  Slankamenac, Ksenija ^a   Breitenstein, Stefan ^a   Beck Schimmer, Beatrice ^b   Graf, Rolf ^a   Puhan, Milo A ^a,c   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; PROPOFOL; SEVOFLURANE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER FUNCTION; LIVER PROTECTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; REPERFUSION INJURY; RETROSPECTIVE STUDY;

EID: 84869097670     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00570.x     Document Type: Article

References (62)

1. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, et al,. (2008) A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 248: 909-918.
2. Clavien PA, Yadav S, Sindram D, Bentley RC,. (2000) Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232: 155-162. (Pubitemid 30616712)
3. Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA,. (2005) How should transection of the liver be performed?: A prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg 242: 814-822. discussion 822-3.
4. Pringle JHV,. (1908) Notes on the Arrest of Hepatic Hemorrhage Due to Trauma. Ann Surg 48: 541-549.
5. Si-Yuan FU, Yee LW, Guang-Gang L, Qing-He T, Ai-Jun LI, Ze-Ya PA, et al,. (2011) A prospective randomized controlled trial to compare Pringle maneuver, hemihepatic vascular inflow occlusion, and main portal vein inflow occlusion in partial hepatectomy. Am J Surg 201: 62-69.
6. Clavien PA, Petrowsky H, DeOliveira ML, Graf R,. (2007) Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 356: 1545-1559. (Pubitemid 46588419)
7. Gozzetti G, Mazziotti A, Grazi GL, Jovine E, Gallucci A, Gruttadauria S, et al,. (1995) Liver resection without blood transfusion. Br J Surg 82: 1105-1110.
8. Kimura F, Miyazaki M, Suwa T, Sugiura T, Shinoda T, Itoh H, et al,. (2002) Evaluation of total hepatic vascular exclusion and pringle maneuver in liver resection. Hepatogastroenterology 49: 225-230. (Pubitemid 34289524)
9. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP, et al,. (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237: 860-869. discussion 869-70.
10. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, et al,. (1999) Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 229: 369-375. (Pubitemid 30191772)
11. Chouker A, Martignoni A, Schauer R, Dugas M, Rau HG, Jauch KW, et al,. (2005) Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils. Arch Surg 140: 129-136. (Pubitemid 40229099)
12. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al,. (2003) A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238: 843-850. discussion 851-2.
13. Horiuchi T, Muraoka R, Tabo T, Uchinami M, Kimura N, Tanigawa N,. (1995) Optimal cycles of hepatic ischemia and reperfusion for intermittent pedicle clamping during liver surgery. Arch Surg 130: 754-758.
14. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien PA,. (2006) A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 244: 921-928. discussion 928-30. (Pubitemid 44808626)
15. Yadav SS, Sindram D, Perry DK, Clavien PA,. (1999) Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 30: 1223-1231. (Pubitemid 29510861)
16. El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, et al,. (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250: 691-697.
17. Slankamenac K, Breitenstein S, Held U, Beck-Schimmer B, Puhan MA, Clavien PA,. (2009) Development and validation of a prediction score for postoperative acute renal failure following liver resection. Ann Surg 250: 720-728.
18. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, et al,. (1998) Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 187: 620-625. (Pubitemid 28557801)
19. Bhattacharya S, Jackson DJ, Beard CI, Davidson BR,. (1999) Central venous pressure and its effects on blood loss during liver resection. Br J Surg 86: 282-283. (Pubitemid 29090206)
20. Clavien PA, Barkun J, de, Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al,. (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250: 187-196.
21. Solari ME,. (1967) Chakravarti,Im-handbook of methods of applied statistics. Nature 216: 901-908.
22. Vardeman S,. (1984) Graphical Methods for Data-Analysis-Chambers,J, Cleveland,W, Kleiner,B, Tukey,P. JQT 16: 177-178.
23. Nobre JS, da Motta Singer J,. (2007) Residual analysis for linear mixed models. Biom J 49: 863-875.
24. Mullenheim J, Ebel D, Frassdorf J, Preckel B, Thamer V, Schlack W,. (2002) Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 96: 934-940. (Pubitemid 34266688)
25. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC,. (2004) Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 100: 707-721. (Pubitemid 38268893)
26. Cope DK, Impastato WK, Cohen MV, Downey JM,. (1997) Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 86: 699-709. (Pubitemid 27118354)
27. Miller R,. (2005) Anesthesia. New York, NY: Churchill Livingstone, pp. 2009-2229.
28. Apfel CC, Stoecklein K, Lipfert P,. (2005) PONV: a problem of inhalational anaesthesia? Best Pract Res Clin Anaesthesiol 19: 485-500. (Pubitemid 40753814)
29. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P,. (1999) Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 100 (Suppl.): II340-II344. (Pubitemid 29523557)
30. De Hert SG, Preckel B, Schlack WS,. (2009) Update on inhalational anaesthetics. Curr Opin Anaesthesiol 22: 491-495.
31. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, et al,. (2004) Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 101: 299-310. (Pubitemid 38988484)
32. Landoni G, Bignami E, Oliviero F, Zangrillo A,. (2009) Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia. Ann Card Anaesth 12: 4-9.
33. Yao YT, Li LH, Chen L, Wang WP, Li LB, Gao CQ,. (2010) Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of radical oxygen species, extracellular signal-related kinases 1/2 and mitochondrial permeability transition pore. Mol Biol Rep 37: 2439-2446.
34. Cason BA, Gamperl AK, Slocum RE, Hickey RF,. (1997) Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 87: 1182-1190. (Pubitemid 27469318)
35. Toombs CF, Moore TL, Shebuski RJ,. (1993) Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 27: 617-622. (Pubitemid 23144586)
36. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, et al,. (2004) Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62: 74-85. (Pubitemid 38326813)
37. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al,. (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588. (Pubitemid 36885888)
38. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR,. (2002) Is isoflurane-induced preconditioning dose related? Anesthesiology 96: 675-680. (Pubitemid 34193509)
39. Obal D, Scharbatke H, Barthel H, Preckel B, Mullenheim J, Schlack W,. (2003) Cardioprotection against reperfusion injury is maximal with only two minutes of sevoflurane administration in rats. Can J Anaesth 50: 940-945. (Pubitemid 38139543)
40. Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, et al,. (2006) Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth 20: 477-483. (Pubitemid 44119282)
41. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, et al,. (2007) Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 24: 323-331.
42. Bignami E, Biondi-Zoccai G, Landoni G, Fochi O, Testa V, Sheiban I, et al,. (2009) Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth 23: 594-599.
43. Landoni G, Calabro MG, Marchetti C, Bignami E, Scandroglio AM, Dedola E, et al,. (2007) Desflurane versus propofol in patients undergoing mitral valve surgery. J Cardiothorac Vasc Anesth 21: 672-677. (Pubitemid 47464944)
44. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, et al,. (2007) ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the american society of echocardiography, american society of nuclear cardiology, heart rhythm society, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society for vascular medicine and biology, and society for vascular surgery. J Am Coll Cardiol 50: 1707-1732.
45. Zangrillo A, Testa V, Aldrovandi V, Tuoro A, Casiraghi G, Cavenago F, et al,. (2011) Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study. J Cardiothorac Vasc Anesth 25: 902-907.
46. Ko JS, Gwak MS, Choi SJ, Kim GS, Kim JA, Yang M, et al,. (2008) The effects of desflurane and propofol-remifentanil on postoperative hepatic and renal functions after right hepatectomy in liver donors. Liver Transpl 14: 1150-1158.
47. Song JC, Sun YM, Yang LQ, Zhang MZ, Lu ZJ, Yu WF,. (2010) A comparison of liver function after hepatectomy with inflow occlusion between sevoflurane and propofol anesthesia. Anesth Analg 111: 1036-1041.
48. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, et al,. (2004) Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109: 784-789. (Pubitemid 38222900)
49. Wolfs TG, Buurman WA, van, Schadewijk A, de, Vries B, Daemen MA, Hiemstra PS, et al,. (2002) In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168: 1286-1293. (Pubitemid 34094497)
50. Wu HS, Zhang JX, Wang L, Tian Y, Wang H, Rotstein O,. (2004) Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 3: 250-253. (Pubitemid 38660160)
51. Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C, et al,. (2005) Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J 19: 1617-1626. (Pubitemid 41429519)
52. Obal D, Weber NC, Zacharowski K, Toma O, Dettwiler S, Wolter JI, et al,. (2005) Role of protein kinase C-epsilon (PKCepsilon) in isoflurane-induced cardioprotection. Br J Anaesth 94: 166-173. (Pubitemid 40214420)
53. Ayuse T, Brienza N, Revelly JP, Boitnott JK, Robotham JL,. (1995) Role of nitric oxide in porcine liver circulation under normal and endotoxemic conditions. J Appl Physiol 78: 1319-1329.
54. Clemens MG,. (1999) Nitric oxide in liver injury. Hepatology 30: 1-5. (Pubitemid 29300561)
55. Mathie RT, Ralevic V, Alexander B, Burnstock G,. (1991) Nitric oxide is the mediator of ATP-induced dilatation of the rabbit hepatic arterial vascular bed. Br J Pharmacol 103: 1602-1606.
56. Maines MD,. (1997) The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554. (Pubitemid 27238886)
57. Maines MD,. (2005) The heme oxygenase system: update 2005. Antioxid Redox Signal 7: 1761-1766. (Pubitemid 41768008)
58. Ryter SW, Alam J, Choi AM,. (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650.
59. Otterbein LE, Soares MP, Yamashita K, Bach FH,. (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455. (Pubitemid 36928103)
60. Hoetzel A, Leitz D, Schmidt R, Tritschler E, Bauer I, Loop T, et al,. (2006) Mechanism of hepatic heme oxygenase-1 induction by isoflurane. Anesthesiology 104: 101-109.
61. Schmidt R, Tritschler E, Hoetzel A, Loop T, Humar M, Halverscheid L, et al,. (2007) Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury. Ann Surg 245: 931-942. (Pubitemid 46809295)
62. De Hert SG,. (2011) Cardioprotection by volatile anesthetics: what about noncardiac surgery? J Cardiothorac Vasc Anesth 25: 899-901.